Sunday, February 16, 2020

Sunday, February 16, 2020

Latest News

6 drugs recalled during June, FDA reports

Six drugs were recalled in June to protect patients from possible harmful defects associated with the products, the U.S. Food and Drug Administration reported.

U.S. FOOD AND DRUG ADMINISTRATION: Statement on steps to make health care professional and patient labeling information for prescription medications consistent and clear

The FDA is committed to making sure that health care professionals and patients have up-to-date, accurate and actionable information about prescription medications so that informed treatment decisions can be made. We recognize that the choice of which medication to use, if any, for a particular patient is often a complex decision.

FDA warns of infection risk from fecal microbiota transplants

Patients who receive fecal microbiota for transplant (FMT) are at risk of life-threatening infections, the Food and Drug Administration said.

U.S. FOOD AND DRUG ADMINISTRATION: Statement on stem cell clinic permanent injunction and FDA’s ongoing efforts to protect patients from risks of unapproved products

U.S. District Judge Ursula Ungaro of the Southern District of Florida issued an order that stops US Stem Cell Clinic LLC, of Weston, Florida, and US Stem Cell Inc., of Sunrise, Florida, and their Chief Scientific Officer Kristin Comella, Ph.D., from manufacturing or distributing any and all stromal vascular fraction (SVF) products, which are adipose (fat) tissue derived stem cell products, until they come into compliance with the law.

Life Rising’s dietary supplements seized over potential consumer risk

U.S. Marshals seized over 300,000 containers of Life Rising Corporation’s dietary supplements in a raid requested by the Food and Drug Administration.

FDA launched 7 foodborne disease probes in first 6 months of 2019

Seven outbreaks of foodborne illnesses have been reported so far this year, according to the U.S. Food and Drug Administration.

FDA improving its regulation of cannabis products: Kline

The FDA is working toward better regulation of cannabis-based products, consulting services firm Kline said after a public hearing with the U.S. regulatory body.

46 food, dietary supplement recalls initiated

Food producers carried out 46 food or dietary supplement product recalls over the past month, according to the U.S. Food and Drug Administration.

5 drugs recalled during May, FDA reports

Five drugs were recalled in May to protect patients from possible harmful defects associated with the products, the U.S. Food and Drug Administration reported.

New added sugar labeling policy could be sweet news for FDA, consumers

The Food and Drug Administration's (FDA) recently announced a mandatory added sugar labeling policy for packaged foods and beverages, set to take effect between 2020 and 2021.

Curio Wellness wants cannabis to be regulated under Federal Food, Drug and Cosmetic Act

Curio Wellness, the market-leading medicinal cannabis company in Maryland, presented a scientifically grounded, patient-focused perspective to de-schedule cannabis and have it regulated under the Food and Drug Administration’s Federal Food, Drug, and Costmetic Act.

Recall on Beckman analyzers affected over 2,000 laboratories

Over 2,000 U.S. laboratories ranging from small hospitals to large medical centers have been affected and notified by the U.S. Food and Drug Administration that the Beckman Coulter DxH 800, DxH 600 and DxH 900 hematology analyzer are now under a Class 1 recall.

U.S. FOOD AND DRUG ADMINISTRATION: FDA puts company on notice for marketing unapproved stem cell products for treating serious conditions

Arizona company claims their products can treat Lyme disease, diabetes, Parkinson’s disease and more, but have not been approved for any use

Pharmacology expert says FDA needs to have more oversight over homeopathic products

The U.S. Food and Drug Administration recently sent letters to companies that produce homeopathic products claiming they were in violation of current good manufacturing practice (CGMP) regulations.

FDA Update: April medical device recalls

Recalls of medical devices occur when a company sees a need to either take corrective action or remove a potentially hazardous device from the market, according to the U.S. Food and Drug Administration.

Doctors support FDA in its claim against 'worthless,' 'hocus pocus' homeopathic drugs

The U.S. Food and Drug Administration sent letters to companies that produce homeopathic products claiming they were in violation of current good manufacturing practice (CGMP) regulations.

FDA Health News